BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CRTC1, Q6UUV9, 23373, ENSG00000105662, KIAA0616, TORC1, MECT1, WAMTP1, FLJ14027
7 results:

  • 1. The GATOR2 complex maintains lysosomal-autophagic function by inhibiting the protein degradation of MiT/TFEs.
    Yang S; Ting CY; Lilly MA
    Mol Cell; 2024 Feb; 84(4):727-743.e8. PubMed ID: 38325378
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Whole-exome sequencing reveals the etiology of the rare primary hepatic mucoepidermoid carcinoma.
    Hou P; Su X; Cao W; Xu L; Zhang R; Huang Z; Wang J; Li L; Wu L; Liao W
    Diagn Pathol; 2021 Apr; 16(1):29. PubMed ID: 33832503
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. "pancreatic Mucoepidermoid Carcinoma" Is not a pancreatic Counterpart of crtc1/3-MAML2 Fusion Gene-related Mucoepidermoid Carcinoma of the Salivary Gland, and May More Appropriately be Termed pancreatic Adenosquamous Carcinoma With Mucoepidermoid Carcinoma-like Features.
    Saeki K; Ohishi Y; Matsuda R; Mochidome N; Miyasaka Y; Yamamoto H; Koga Y; Maehara Y; Nakamura M; Oda Y
    Am J Surg Pathol; 2018 Nov; 42(11):1419-1428. PubMed ID: 30138216
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Enhanced mitochondrial glutamine anaplerosis suppresses pancreatic cancer growth through autophagy inhibition.
    Jeong SM; Hwang S; Park K; Yang S; Seong RH
    Sci Rep; 2016 Aug; 6():30767. PubMed ID: 27477484
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer.
    Venkannagari S; Fiskus W; Peth K; Atadja P; Hidalgo M; Maitra A; Bhalla KN
    Oncotarget; 2012 Nov; 3(11):1416-27. PubMed ID: 23232026
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathway.
    Wallin JJ; Edgar KA; Guan J; Berry M; Prior WW; Lee L; Lesnick JD; Lewis C; Nonomiya J; Pang J; Salphati L; Olivero AG; Sutherlin DP; O'Brien C; Spoerke JM; Patel S; Lensun L; Kassees R; Ross L; Lackner MR; Sampath D; Belvin M; Friedman LS
    Mol Cancer Ther; 2011 Dec; 10(12):2426-36. PubMed ID: 21998291
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.
    Tonon G; Modi S; Wu L; Kubo A; Coxon AB; Komiya T; O'Neil K; Stover K; El-Naggar A; Griffin JD; Kirsch IR; Kaye FJ
    Nat Genet; 2003 Feb; 33(2):208-13. PubMed ID: 12539049
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.